Essential phospholipids as a supportive adjunct in the management of patients with NAFLD.

Background And Study Aims: Treatment of nonalcoholic fatty liver (NAFLD) is important because NAFLD patients have a 1.7-fold increase in standardised age and gender matched mortality. Currently treatment is based on life style modification and managing comorbid associating disease.